Artivion has seen its share price fall sharply over the past year, even as the business reports higher revenue and prepares new products for market. With the stock now trading around US$20.64, the key question is whether that price still lines up with what the company is generating in sales. The share price has declined 54.1% over the past year, which puts the focus squarely on whether the current market value is still in step with Artivion's revenue base. Recent double digit revenue growth,...
Artivion (AORT) delivered earnings and revenue surprises of -27.27% and +1.97%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Medical device company Artivion (NYSE:AORT) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 9.2% year on year to $123.8 million. On the other hand, the company’s full-year revenue guidance of $488 million at the midpoint came in 0.5% below analysts’ consensus estimates. Its non-GAAP profit of $0.08 per share was 21.2% above analysts’ consensus estimates.
Artivion (NYSE:AORT) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our
On August 6, Artivion Inc. (NYSE:AORT) reported second-quarter 2026 results that read as if two different companies wrote them. Revenue for the quarter ended June 30 climbed 11% on a GAAP basis to $125.8 million, and the company finished assembling what it calls the only complete aortic arch portfolio in its industry. Yet the same […]
Andrew M Green, Senior Vice President, Regulatory and Quality, on September 10, 2026, sold 11,480 sh
Artivion stock has delivered a 57.6% gain over the past three years, yet current valuation checks suggest the shares now sit close to their estimated intrinsic value, rather than offering a clear discount. With the Discounted Cash Flow (DCF) estimate and market multiples both pointing to pricing that looks broadly in line with fundamentals, the stock no longer looks obviously cheap or obviously expensive. Artivion is up 57.6% over three years. This means anyone looking at the stock today is...
Artivion (AORT) has drawn fresh attention after recent share price swings, with the stock up 3.1% in the latest session but still down 38.8% year to date as of 27 August 2026. Artivion’s recent 1 day share price return of 3.11% comes after a 7 day share price decline of 5.62%, with the stock still showing a year to date share price loss of 38.82%. The 3 year total shareholder return is 55.25%, suggesting longer term holders have seen a very different experience to recent buyers. Balance...
This is the newest page. Registered accounts read further back.